0001722760-23-000001.txt : 20230321 0001722760-23-000001.hdr.sgml : 20230321 20230321172056 ACCESSION NUMBER: 0001722760-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230321 DATE AS OF CHANGE: 20230321 EFFECTIVENESS DATE: 20230321 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Phase Genomics, Inc. CENTRAL INDEX KEY: 0001722760 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-476536 FILM NUMBER: 23750546 BUSINESS ADDRESS: STREET 1: 4000 MASON ROAD STREET 2: SUITE 225 CITY: SEATTLE STATE: WA ZIP: 98195 BUSINESS PHONE: 206-384-6228 MAIL ADDRESS: STREET 1: 4000 MASON ROAD STREET 2: SUITE 225 CITY: SEATTLE STATE: WA ZIP: 98195 D 1 primary_doc.xml X0708 D LIVE 0001722760 Phase Genomics, Inc. 1617 8th Ave. North SEATTLE WA WASHINGTON 98109 206-384-6228 DELAWARE None None Corporation true Ivan Liachko c/o Phase Genomics, Inc. 1617 8th Ave. North Seattle WA WASHINGTON 98109 Executive Officer Director Promoter Shawn Sullivan c/o Phase Genomics, Inc. 1617 8th Ave. North Seattle WA WASHINGTON 98109 Executive Officer Promoter Kayla Young c/o Phase Genomics, Inc. 1617 8th Ave. North Seattle WA WASHINGTON 98109 Executive Officer Biotechnology Decline to Disclose 06b false 2023-03-14 false true true true true true Convertible Promissory Notes false 0 6579358 4754364 1824994 false 13 0 0 0 false Phase Genomics, Inc. Ivan Liachko Ivan Liachko Chief Executive Officer 2023-03-21